AURO-RAMIPRIL CAPSULE

Држава: Канада

Језик: Енглески

Извор: Health Canada

Активни састојак:

RAMIPRIL

Доступно од:

AURO PHARMA INC

АТЦ код:

C09AA05

INN (Међународно име):

RAMIPRIL

Дозирање:

2.5MG

Фармацеутски облик:

CAPSULE

Састав:

RAMIPRIL 2.5MG

Пут администрације:

ORAL

Јединице у пакету:

30/100/500

Тип рецептора:

Prescription

Терапеутска област:

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS

Резиме производа:

Active ingredient group (AIG) number: 0122858004; AHFS:

Статус ауторизације:

APPROVED

Датум одобрења:

2012-08-24

Карактеристике производа

AURO-RAMIPRIL PRODUCT MONOGRAPH PAGE 1 OF 44
PRODUCT MONOGRAPH
PR
AURO-RAMIPRIL
Ramipril Capsules
1.25 mg, 2.5 mg, 5 mg and 10 mg
BP
ATC Code: C09AA05
Angiotensin Converting Enzyme Inhibitor
AURO PHARMA INC.
3700 Steeles Avenue West, Suite # 402
Woodbridge, Ontario, L4L 8K8,
Canada
Date of Revision:
January 11, 2023
Submission Control No.: 266581
AURO-RAMIPRIL PRODUCT MONOGRAPH PAGE 2 OF 44
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
...................................................... 3
SUMMARY PRODUCT INFORMATION
............................................................................
3
INDICATIONS AND CLINICAL USE
.................................................................................
3
CONTRAINDICATIONS
.....................................................................................................
4
WARNINGS AND PRECAUTIONS
.....................................................................................
5
ADVERSE
REACTIONS.....................................................................................................12
DRUG INTERACTIONS
.....................................................................................................17
DOSAGE AND ADMINISTRATION
..................................................................................21
OVERDOSAGE
..................................................................................................................23
ACTION AND CLINICAL
PHARMACOLOGY..................................................................24
STORAGE AND STABILITY
.............................................................................................27
DOSAGE FORMS, COMPOSITION AND PACKAGING
...................................................27
PART II: SCIENTIFIC INFORMATION
........................................................................
29
PHARMACEUTICAL INFORMATION
..............................................................................29
CLINICAL TRIALS
.........................................................